Medication info
EJIMTINE 10 mg (Memantine Hydrochloride)

EJIMTINE 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201800794 · Approved 2018.02.09 · Insurance code 670607840

Summary

Main use
Treatment of moderate to severe Alzheimer’s disease
Who takes it
Adults
Adult dose
1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg once daily for 7 days. Week 2 (Days 8~14): Administer 10mg per day (5mg twice daily) for 7 days. Week 3 (Days 15~21): Administer 15mg per day (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg per day (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg per day (10mg twice daily). 2. Elderly patients: Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg per day (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg per day according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer’s disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg once daily for 7 days. Week 2 (Days 8~14): Administer 10mg per day (5mg twice daily) for 7 days. Week 3 (Days 15~21): Administer 15mg per day (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg per day (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg per day (10mg twice daily). 2. Elderly patients: Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg per day (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg per day according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This drug should not be used in patients who are allergic to any of its ingredients or have severe liver or kidney impairment. Patients with epilepsy or a history of seizures, as well as those taking certain other medications, may experience exacerbated side effects and should exercise caution. Patients with changes in urine acidity or heart disease should also be cautious when using this drug. Common side effects reported in patients taking this medication include dizziness, headache, constipation, drowsiness, and hypertension; psychiatric symptoms have been reported rarely. This drug can interact with other central nervous system medications, so be sure to inform your healthcare provider of any other drugs you are taking. Women who are pregnant or breastfeeding should consult a doctor before taking this medication and should use it cautiously if there is a possibility of pregnancy. The safety and efficacy of this drug in children and adolescents under 18 years of age have not been established. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may appear, so contact a medical institution immediately for appropriate treatment. This drug may affect patients' reaction times, so caution is advised when driving or operating machinery. Store in a place out of reach of children and keep it in its original container for safety.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug allergy
  • confusion
  • hallucination
  • psychotic response
Show 24 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific tiredness
  • weakness
  • diarrhea
  • anxiety
  • aggressiveness
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.